NEW COSMO26 — Social Media in Oncology: top voices, key slides & takeaways, decoded View Full Coverage →
KOL Pulse AI · Conference Intelligence · Multiple Myeloma
ASCO 2026 myeloma Virtual Attendee Network
248 accounts classified from 155 curated myeloma tweets at ASCO 2026 Annual Meeting (Multiple Myeloma). Filter the entire page by myeloma trial, or click any KOL to view their engagement cohort.
See who amplifies whom → myeloma Influencer Networks
248 Identified Accounts 57 Verified US Physicians 113 Int'l Physicians 31 Countries
Top 10 myeloma KOLs ranked by 25×25 engagement · Click a KOL to view their engagement cohort
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • ✓Enhanced KOL profiles
  • ✓Pharma influence & potential advisory-board patterns
  • ✓2025 Open Payments financial analysis
  • ✓Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.
Category Breakdown
Physicians by Region / Country
Network
Top Accounts

Methodology

Accounts were captured from 155 myeloma tweets curated at ASCO 2026 and classified into physician (US / international), researcher, pharma, institution, media, patient-advocate and general-public categories via the KOL Pulse account registry. US physicians are cross-referenced against CMS Open Payments. Top-10 KOLs are ranked by the locked 25×25 engagement formula (retweets, quotes, replies, mentions among the tumor's top voices). Trial attribution ties an account to a myeloma trial when it authored a tweet tagged to that trial or engaged a KOL who did. Real accounts only; no synthetic voices.